These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 6776297
1. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma. Hollister D, Coleman M. JAMA; 1980 Nov 07; 244(18):2065-7. PubMed ID: 6776297 [Abstract] [Full Text] [Related]
2. Thiotepa-induced myelosuppression: review of 670 bladder instillations. Soloway MS, Ford KS. J Urol; 1983 Nov 07; 130(5):889-91. PubMed ID: 6415297 [Abstract] [Full Text] [Related]
6. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma. Mitchell RJ. Br J Urol; 1971 Apr 07; 43(2):185-8. PubMed ID: 4996214 [No Abstract] [Full Text] [Related]
7. Acute nonlymphocytic leukemia following bladder instillations with thiotepa. Easton DJ, Poon MA. Can Med Assoc J; 1983 Sep 15; 129(6):578-9. PubMed ID: 6411320 [Abstract] [Full Text] [Related]
8. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa. Treible DP, Skinner D, Kasimain D, Friedman NB, Kern WH. Urology; 1987 Dec 15; 30(6):568-70. PubMed ID: 3120389 [Abstract] [Full Text] [Related]
9. Chemotherapy for bladder cancer. Veenema RJ, Romas NA, Fingerhut B. Urology; 1974 Feb 15; 3(2):135-9. PubMed ID: 4204755 [No Abstract] [Full Text] [Related]
10. Oxyphenbutazone (Tanderil) and blood dyscrasia. Brownlie BE, Strang PJ. N Z Med J; 1969 Feb 15; 69(441):77-9. PubMed ID: 5252205 [No Abstract] [Full Text] [Related]
11. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature. Silberberg JM, Zarrabi MH. J Urol; 1987 Aug 15; 138(2):402-3. PubMed ID: 3110436 [Abstract] [Full Text] [Related]
14. [Depression of bone marrow after intravesical use of Thio-tepa]. Malling N. Ugeskr Laeger; 1980 Sep 29; 142(40):2630-1. PubMed ID: 6777928 [No Abstract] [Full Text] [Related]
15. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. Veenema RJ, Dean AL, Uson AC, Roberts M, Longo F. J Urol; 1969 May 29; 101(5):711-5. PubMed ID: 4976352 [No Abstract] [Full Text] [Related]
16. Phase I/pharmacokinetic reevaluation of thioTEPA. O'Dwyer PJ, LaCreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, DeVito J, Poplack D, DeLap RJ. Cancer Res; 1991 Jun 15; 51(12):3171-6. PubMed ID: 1710167 [Abstract] [Full Text] [Related]
17. [Toxic reactions during treatment of the ovarian cancer with ThioTEPA]. Shuvaeva NI, Emel'ianova LS. Akush Ginekol (Mosk); 1974 Oct 15; (10):18-20. PubMed ID: 4216276 [No Abstract] [Full Text] [Related]
18. [The morphologic composition of peripheral blood following intra-arterial infusion of 5-fluorouracil and alkylating preparations in stomach cancer patients]. Chernyĭ VA. Vopr Onkol; 1970 Apr 15; 16(4):61-4. PubMed ID: 4989339 [No Abstract] [Full Text] [Related]
19. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P. Prog Clin Biol Res; 1989 Apr 15; 310():237-52. PubMed ID: 2505269 [Abstract] [Full Text] [Related]